Skip to main content

Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.

An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.

Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.

This chapter was published in IP in the Life Sciences.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
Jul 17, 2026

First published by Lexology. Authors: Sandhya Singh and Sampada Kapoor Modern sport is no longer merely an athletic competition; it is a multi-billion-dollar

Managing Ambush Marketing: Legal and Commercial Perspectives
News & Updates, Thought Leadership
Jul 16, 2026

First published by IP Stars. Authors: Safir Anand and Sehr Anand In a digital landscape where the internet never forgets, an individual’s past can

The Right Not to Be Published: Inside the Delhi High Court’s Landmark ‘Right to Be Forgotten’ Judgment
News & Updates, Thought Leadership
Jul 14, 2026

First published by Lexology. Authors: Lakshmidevi Somanath and Kanishka Vaish I. The Quiet Trend of Strong Evidence Engineering Anyone who has appeared

Evidence Engineering in IP Litigation
News & Updates, Thought Leadership
Jul 14, 2026

‘First published on Legal Era’ By: Safir Anand and Omesh Puri Understanding copyright ownership in Short-Form Videos For decades, businesses measured

Understanding copyright ownership in Short-Form Videos